Letters to the Editor

Myelodysplastic syndrome with concomitant SF3B1 mutation and deletion of chromosome 5 long arm: outcomes and response to treatment

Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
Department of Internal Medicine, Section of Medical Oncology and Hematology, Yale University School of Medicine and Yale Cancer Center
Department of Internal Medicine, Section of Medical Oncology and Hematology, Yale University School of Medicine and Yale Cancer Center
Vanderbilt University Medical Center, Nashville, TN
Vanderbilt University Medical Center, Nashville, TN
Vanderbilt University Medical Center, Nashville, TN
MDS Unit, Hematology, AOUC, University of Florence, Florence
MDS Unit, Hematology, AOUC, University of Florence, Florence
Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig
Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig
Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX
Department of Hematology, Université de Paris, Saint-Louis Hospital, Paris
Department of Hematology, Université de Paris, Saint-Louis Hospital, Paris
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
IRCCS Humanitas Research Hospital, Rozzano, Milan
IRCCS Humanitas Research Hospital, Rozzano, Milan
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX
Department of Hematology, Salamanca-IBSAL University Hospital, Salamanca
Department of Hematology, Salamanca-IBSAL University Hospital, Salamanca
Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX
Haematologica Early view May 7, 2026 https://doi.org/10.3324/haematol.2025.300396